Other Headlines

Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.
The medical community pays tribute to a dedicated crew.
GI monitoring device promises to speed the evaluation and treatment of GI motility disorders.
DOTmed discusses the American Society for Therapeutic Radiation Oncology (ASTRO) program for public awareness with ASTRO's assistant director of communications, Beth Bukata.
A novel microfluidic drug delivery system makes it possible to reach parts of the body poorly served by oral and injectable medications.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

House Passes Medicare Physician Payment Reform Act Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.

Aural Trumps Oral for Ear Treatment A novel microfluidic drug delivery system makes it possible to reach parts of the body poorly served by oral and injectable medications.

Scientists Find Unusual Immune System Activity in Brains of Schizophrenics The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.

Clinical PET-MRI Moves Closer to Reality Thanks to a European grant for the HyperIMAGE project, a consortium of scientists across Europe have worked with Philips to develop a proof-of-concept, pre-clinical combined MR-PET scanner that could one day lead to improved radiation therapy and cardiology treatments.

Senate Health Care Reform Bill Unveiled Legislation may go to cloture vote this weekend. Read the details.

RSNA 2009 Preview This year's RSNA should provide a very interesting look at the effects of the economy on the major OEMs. As always, vendors are whipping up the hoopla, and inside this story are great previews of what's being debuted. But DOTmed reporters will also be there to get the real buzz. Look for video interviews in our Online News direct from the show.

Interview With Fred Robertson, President & CEO of TomoTherapy TomoTherapy president and CEO Fred Robertson talks with DOTmed about his perspective on ASTRO's 2009 annual meeting, changes in the radiation oncology industry and two important TomoTherapy product launches that occurred at the show. Watch the HD video.

Pen-Sized Microscope Aims for Precise Brain Surgeries A confocal microscope picking up brain-safe fluorescent dyes could result in more accurate and streamlined surgeries to remove tumors from the brain.

Health Care Reform Round-Up: CBO Pegs Senate Bill at $849 Billion The numbers are in on the Senate's version of reform. Also read about the wide-ranging impact that the legislation would have.

U.S. Preventive Services Task Force Has Stunning New Guidelines on Mammography Agency recommends no routine screening for women 40-49, no self-examination. Read the details.

Are cell phones
hazardous to health?

Debate Over Cell Phone Risk Continues

by Astrid Fiano, DOTmed News Writer
Are cell phones safe? Could they contribute to cancer risk? Are fears overblown, or do we face an impending health crisis?

Questions regarding the possible detrimental health effects of cell phone usage are being raised again, a topic that has been fiercely debated in medical and advocacy circles.

At the forefront of publicizing the possible risks is the University of Pittsburgh Cancer Institute's Center for Environmental Oncology. The Center has a prominent online article entitled "The Case for Precaution in the Use of Cell Phones." The information in the article explains the transmission of electromagnetic fields from cell phones. The site offers ten precautions cell phone users can take, including using the speakerphone or Bluetooth headset attachment, and texting rather than phoning.

In addition, the House Committee on Oversight and Government Reform Subcommittee on Domestic Policy held a hearing last week entitled "Cell Phone Use and Tumors: What the Science Says." Witnesses included Dr. Ronald B. Herberman, the Director of the University of Pittsburgh Cancer Institute, who reiterated in his testimony -- the same concerns expressed in the Center for Environmental Oncology website. The Subcommittee also heard from Dr. David O. Carpenter, the Director of Institute for Health and the Environment for University of Albany. Dr. Carpenter is a co-editor and co-author of a the chapter in the Bioinitiative Report published last year, which deals with the public-health implications of electromagnetic fields. Dr. Carpenter testified that national and international reviews on the dangers are excessively conservative and that current exposure guidelines do not adequately protect the health of the public.

Other experts are more cautious about the potential risks. The Federal Communications Commission (FCC) and the Food and Drug Administration (FDA) each regulate wireless telephones and the FDA monitors the health effects of wireless telephones. On the FDA's website addressing the question of safety, the Agency states: "The available scientific evidence does not show that any health problems are associated with using wireless phones. There is no proof, however, that wireless phones are absolutely safe.... Many studies of low level RF exposures have not found any biological effects. Some studies have suggested that some biological effects may occur, but such findings have not been confirmed by additional research."

CTIA - The Wireless Association President and CEO Steve Largent issued a statement regarding the controversy and the House hearing. "CTIA and the wireless industry take the health of our customers very seriously. That is why the wireless industry has supported scientific research on these issues, and also supports the Federal Communications Commission's strict safety guidelines that apply to all wireless devices that are sold or marketed in the U.S....The available scientific evidence and expert reviews from leading global health organizations such as the American Cancer Society, National Cancer Institute, United States Food and Drug Administration and the World Health Organization reflect a consensus based on published scientific research showing that there is no reason for concern."

Largent also pointed out the commentary from a U.S. National Institutes of Health National Cancer Institute bulletin. In that bulletin, the NCI states emphatically that the risks of cancer -- are not supported by a growing body of research on the subject.

The bulletin states that the dozen studies that have explored the relationship between the use of cell phones and malignant or benign brain tumors have found little or no overall increased risk of brain tumors within the first 10 years of use. Advisors to the NCI say that they are still not seeing convincing evidence of an increased brain cancer risk. Still unanswered, the NCI says, is how cell phones might contribute to cancer. "While exposure to high levels of radio frequency energy can heat body tissues," the website says, "the amount of radiofrequency energy produced by cell phones is too low to cause significant heating of tissue."

Center for Environmental Oncology's website: http://www.environmentaloncology.org/node/201
NCI Bulletin: http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_092308/page7
House Committee website: http://domesticpolicy.oversight.house.gov/story.asp?ID=2199

Ed note: Many DOTmed users are expert biomedical engineers or clinicians. We we welcome your comments about the relative dangers or safety of RF exposure. Click below to send us your comments.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED